These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25534989)

  • 1. Lipophilic prodrug conjugates allow facile and rapid synthesis of high-loading capacity liposomes without the need for post-assembly purification.
    Mikhalin AA; Evdokimov NM; Frolova LV; Magedov IV; Kornienko A; Johnston R; Rogelj S; Tartis MS
    J Liposome Res; 2015 Sep; 25(3):232-260. PubMed ID: 25534989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery.
    Márquez MG; Dotson R; Pias S; Frolova LV; Tartis MS
    Nanotheranostics; 2020; 4(1):40-56. PubMed ID: 31911893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment.
    Salmaso S; Mastrotto F; Roverso M; Gandin V; De Martin S; Gabbia D; De Franco M; Vaccarin C; Verona M; Chilin A; Caliceti P; Bogialli S; Marzaro G
    J Control Release; 2021 Dec; 340():318-330. PubMed ID: 34748872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.
    Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L
    Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy.
    Wei X; Patil Y; Ohana P; Amitay Y; Shmeeda H; Gabizon A; Barenholz Y
    Mol Pharm; 2017 Dec; 14(12):4339-4345. PubMed ID: 28045540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic prodrugs of a triazole-containing colchicine analogue in liposomes: biological effects on human tumor cells.
    Kuznetsova NR; Svirshchevskaya EV; Sitnikov NS; Abodo L; Sutorius H; Zapke J; Velder J; Thomopoulou P; Oschkinat H; Prokop A; Schmalz HG; Fedorov AY; Vodovozova EL
    Bioorg Khim; 2013; 39(5):609-18. PubMed ID: 25702420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
    Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
    J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
    Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
    Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry.
    Castelli F; Sarpietro MG; Ceruti M; Rocco F; Cattel L
    Mol Pharm; 2006; 3(6):737-44. PubMed ID: 17140261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism and attenuation of triptolide through prodrug engineering combined with liposomal scaffold strategy to enhance inhibition in pancreatic cancer.
    Chen H; Wang X; Liu M; Yang J; Kuang Y; Wei R; Tai Z; Zhu Q; Chen Z; Chen J; Wu X
    Int J Pharm; 2023 Dec; 648():123623. PubMed ID: 37989402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
    Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
    Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer double lipid prodrugs: liposomal preparation and characterization.
    Arouri A; Mouritsen OG
    J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
    van Borssum Waalkes M; van Galen M; Morselt H; Sternberg B; Scherphof GL
    Biochim Biophys Acta; 1993 May; 1148(1):161-72. PubMed ID: 8499464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results.
    Schwendener RA; Supersaxo A; Rubas W; Weder HG; Hartmann HR; Schott H; Ziegler A; Hengartner H
    Biochem Biophys Res Commun; 1985 Jan; 126(2):660-6. PubMed ID: 3156589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers.
    Sarpietro MG; Ottimo S; Paolino D; Ferrero A; Dosio F; Castelli F
    Int J Pharm; 2012 Oct; 436(1-2):135-40. PubMed ID: 22728161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.